Last reviewed · How we verify

NCT05680025

Effect of a Physical Exercise Intervention Based on the Transtheoretical Model on Blood Pressure

ENROLLING BY INVITATION NA Last updated 29 May 2024
What this trial tests

NA trial testing Physical exercise intervention in Hypertension in 442 participants. Enrolling by invitation.

Timeline
8 August 2022
Primary endpoint
15 December 2023
30 August 2024

Quick facts

Lead sponsorCoordinación de Investigación en Salud, Mexico
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment442
Start date8 August 2022
Primary completion15 December 2023
Estimated completion30 August 2024
Sites1 location across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Coordinación de Investigación en Salud, Mexico — full company profile →

Who can join

Adults 40 to 70, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Hypertension is a public health problem; the World Health Organization (WHO) estimates that more than 1280 million people suffer it. The treatment of said condition is pharmacological and non-pharmacological. Physical activity is part of the treatment, but unfortunately few adults can be classified as physically active. There is evidence that performing physical exercise reduces systolic blood pressure by up to 5 mm Hg, which has associated with reduced heart disease by up to 9%, ictus up to 14% and all-cause mortality by 4%. Lifestyle changing interventions, among them promoting exercise marked by a theory of behavior change, have shown positive results. Objective: To evaluate the effect of an intervention promoting the performance of physical exercise, with specific recommendations, based on the Transtheoretical Model, on systolic blood pressure and on the amount of exercise performed (minutes/week) in patients with hypertension aged 40 to 70 years, users of primary care in the Mexican Institute for Social Security (IMSS) in Aguascalientes. Material and methods: Randomized clinical trial, in which 442 patients with hypertension will participate. The control group will receive conventional care and recommendations for physical exercise and diet. The intervention group, in addition, will attend 6 workshops, one a month, which will promote performing physical exercise, with access given to videos of physical exercise routines, designed to gradually increase the exercise performed. At the start and end of the study, blood pressure, anthropometric measurements will be taken, through a questionnaire asking about sociodemographic data, performance of physical exercise, psychosocial factors regarding physical exercise, diet and adherence to pharmacological treatment. The characteristics of the study population by group will be described, and changes between baseline and final measurements compared, intra and intergroup, in the systolic blood pressure and minutes/week of physical exercise.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of a physical activity promotion intervention based on the transtheoretical model on blood pressure in patients with hypertension attending primary care: a randomized controlled trial.
    Padilla-López J, Torres-Duque L, Muñoz S, Prado-Aguilar CA, et al · · 2026 · PMID 41634617 · DOI 10.1186/s12875-026-03199-4

Verify or expand the search:

Other trials of Physical exercise intervention

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Coordinación de Investigación en Salud, Mexico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05680025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing